760 related articles for article (PubMed ID: 21169138)
1. Aceclofenac topical dosage forms: in vitro and in vivo characterization.
Dua K; Pabreja K; Ramana MV
Acta Pharm; 2010 Dec; 60(4):467-78. PubMed ID: 21169138
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of extemporaneously manufactured topical gels containing aceclofenac on inflammation and hyperalgesia in rats.
Pabreja K; Dua K; Padi SS
Curr Drug Deliv; 2010 Oct; 7(4):324-8. PubMed ID: 20695843
[TBL] [Abstract][Full Text] [Related]
3. Topical dosage form of valdecoxib: preparation and pharmacological evaluation.
Kesavanarayanan KS; Nappinnai M; Ilavarasan R
Acta Pharm; 2007 Jun; 57(2):199-209. PubMed ID: 17507316
[TBL] [Abstract][Full Text] [Related]
4. Formulation and Characterization of Aceclofenac -Aloe vera Transemulgel.
Raju YP; Haritha K; Satyanarayana RP; Vandana KR; Bindu DT; Vinesha V; Chowdary VH
Curr Drug Deliv; 2015; 12(6):703-8. PubMed ID: 25751659
[TBL] [Abstract][Full Text] [Related]
5. Formulation and evaluation of once-a-day transdermal gels of diclofenac diethylamine.
Baboota S; Shakeel F; Kohli K
Methods Find Exp Clin Pharmacol; 2006 Mar; 28(2):109-14. PubMed ID: 16636721
[TBL] [Abstract][Full Text] [Related]
6. Aceclofenac-Galactose Conjugate: Design, Synthesis, Characterization, and Pharmacological and Toxicological Evaluations.
Magliocca S; De Caro C; Lazzarato L; Russo R; Rolando B; Chegaev K; Marini E; Nieddu M; Burrai L; Boatto G; Cristiano C; Marabello D; Gazzano E; Riganti C; Sodano F; Rimoli MG
Mol Pharm; 2018 Aug; 15(8):3101-3110. PubMed ID: 29912563
[TBL] [Abstract][Full Text] [Related]
7. Nanoemulsions as vehicles for transdermal delivery of aceclofenac.
Shakeel F; Baboota S; Ahuja A; Ali J; Aqil M; Shafiq S
AAPS PharmSciTech; 2007 Dec; 8(4):E104. PubMed ID: 18181525
[TBL] [Abstract][Full Text] [Related]
8. Novel elastic membrane vesicles (EMVs) and ethosomes-mediated effective topical delivery of aceclofenac: a new therapeutic approach for pain and inflammation.
Sharma G; Goyal H; Thakur K; Raza K; Katare OP
Drug Deliv; 2016 Oct; 23(8):3135-3145. PubMed ID: 26960815
[TBL] [Abstract][Full Text] [Related]
9. Comparison of the efficacy and skin permeability of topical NSAID preparations used in Europe.
Komatsu T; Sakurada T
Eur J Pharm Sci; 2012 Dec; 47(5):890-5. PubMed ID: 22985876
[TBL] [Abstract][Full Text] [Related]
10. Microemulsion and poloxamer microemulsion-based gel for sustained transdermal delivery of diclofenac epolamine using in-skin drug depot: in vitro/in vivo evaluation.
Fouad SA; Basalious EB; El-Nabarawi MA; Tayel SA
Int J Pharm; 2013 Sep; 453(2):569-78. PubMed ID: 23792042
[TBL] [Abstract][Full Text] [Related]
11. Oral administration of Ginkgo biloba extract, EGb-761 inhibits thermal hyperalgesia in rodent models of inflammatory and post-surgical pain.
Biddlestone L; Corbett AD; Dolan S
Br J Pharmacol; 2007 May; 151(2):285-91. PubMed ID: 17375081
[TBL] [Abstract][Full Text] [Related]
12. Comparison of the anti-inflammatory effect and gastrointestinal tolerability of aceclofenac and diclofenac.
Arañó A; Zapatero MI; Basi N; Duque A; Gropper S
Arzneimittelforschung; 1996 Apr; 46(4):398-400. PubMed ID: 8740087
[TBL] [Abstract][Full Text] [Related]
13. In vitro release, rheological, and stability studies of mefenamic acid coprecipitates in topical formulations.
Ahmed TA; Ibrahim HM; Ibrahim F; Samy AM; Fetoh E; Nutan MT
Pharm Dev Technol; 2011 Oct; 16(5):497-510. PubMed ID: 20550465
[TBL] [Abstract][Full Text] [Related]
14. In vitro release and antiinflammatory activity of topical formulations of ketoprofen.
Moretti MD; Gavini E; Peana AT
Boll Chim Farm; 2000; 139(2):67-72. PubMed ID: 10920531
[TBL] [Abstract][Full Text] [Related]
15. Release study of diclofenac from new carbomer gels.
Bregni C; Chiappetta D; Faiden N; Carlucci A; García R; Pasquali R
Pak J Pharm Sci; 2008 Jan; 21(1):12-6. PubMed ID: 18166512
[TBL] [Abstract][Full Text] [Related]
16. Topical anti-inflammatory and analgesic activities of standardized pomegranate rind extract in comparison with its marker compound ellagic acid in vivo.
Mo J; Panichayupakaranant P; Kaewnopparat N; Nitiruangjaras A; Reanmongkol W
J Ethnopharmacol; 2013 Jul; 148(3):901-8. PubMed ID: 23743057
[TBL] [Abstract][Full Text] [Related]
17. Improved bioavailability of aceclofenac from spherical agglomerates: development, in vitro and preclinical studies.
Muatlik S; Usha AN; Reddy MS; Ranjith AK; Pandey S
Pak J Pharm Sci; 2007 Jul; 20(3):218-26. PubMed ID: 17545107
[TBL] [Abstract][Full Text] [Related]
18. Optimization of aceclofenac solid dispersion using Box-Behnken design: in-vitro and in-vivo evaluation.
Maulvi FA; Thakkar VT; Soni TG; Gandhi TR
Curr Drug Deliv; 2014; 11(3):380-91. PubMed ID: 24611664
[TBL] [Abstract][Full Text] [Related]
19. Pharmacology of the potent new non-steroidal anti-inflammatory agent aceclofenac.
Grau M; Guasch J; Montero JL; Felipe A; Carrasco E; Juliá S
Arzneimittelforschung; 1991 Dec; 41(12):1265-76. PubMed ID: 1815528
[TBL] [Abstract][Full Text] [Related]
20. Trials of clear aceclofenac-loaded soft capsules with accelerated oral absorption in human subjects.
Yong CS; Oh YK; Lee KH; Park SM; Park YJ; Gil YS; Yu CH; Yoo BK; Woo JS; Kim JO; Rhee JD; Kim CK; Choi HG
Int J Pharm; 2005 Sep; 302(1-2):78-83. PubMed ID: 16107306
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]